Daito Pharmaceutical Co., Ltd. (TYO:4577)

Daito Pharmaceutical Revenue

Daito Pharmaceutical had revenue of 11.89B JPY in the quarter ending August 31, 2026, a decrease of -8.59%. This brings the company's total for the last twelve months to 49.53B, down -2.83% year-over-year. In the fiscal year ending May 31, 2026, Daito Pharmaceutical had annual revenue of 50.65B with 0.01% growth. That makes Daito Pharmaceutical the 14,326th largest company in the world by revenue and 1,521st in Japan.

• Revenue (ttm): 49.53B
• Revenue Growth: -2.83%
• P/S Ratio: 0.75
• Revenue / Employee: 45.65M
• Employees: 1,085
• Market Cap: 37.22B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
May 31, 2026	50.65B	7.00M	0.01%
May 31, 2025	50.64B	3.75B	7.99%
May 31, 2024	46.90B	1.79B	3.98%
May 31, 2023	45.10B	1.64B	3.77%
May 31, 2022	43.46B	-5.25B	-10.78%

Data Source: S&P Global Market Intelligence Last updated: Oct 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 15, 2026

Data Sources Report a data error